🔴 Neurosense Therapeutics is trading 6.1% down

Neurosense Therapeutics is trading 6.09% down at $4.16 on October 1, 2026; no clear company-specific catalyst for the decline was identified.

• The decline follows losses over the prior three sessions, including a 7.32% drop on September 30.
• The investor-relations page lists no October 1 announcement; its latest listed news is a September 28 conference participation notice.
• Provided major-index moves were below the 0.5% threshold, so available evidence does not establish a broader-market cause.